Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
Go back to Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million| Profile Technologies, Inc. (NASDAQ: PRTK) | Delayed: 2.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $22.00 | |||
| Open | $2.23 | 52 Week Low | $9.80 | |||
| Day High | $2.23 | P/E | N/A | |||
| Day Low | $2.23 | EPS | $-0.08 | |||
| Volume | 863,694 | |||||
